Adult prescription drug use and pediatric medication exposures and poisonings - PubMed (original) (raw)
Adult prescription drug use and pediatric medication exposures and poisonings
Lindsey C Burghardt et al. Pediatrics. 2013 Jul.
Abstract
Background and objectives: Nontherapeutic medication ingestions continue to be a major pediatric health problem, with recent increases in ingestions despite a number of public health interventions. It is unknown how changes in adult prescription drug use relate to pediatric medication poisonings. The objective of the study was to measure the association between changing adult prescription drug patterns and pediatric medication exposures and poisonings and identify high-risk classes of medications and pediatric age groups.
Methods: We measured monthly pediatric exposures and poisonings using the National Poison Data System and prescriptions written for adults using the National Ambulatory Medical Care Surveys for 2000 through 2009. Associations between adult prescriptions for oral hypoglycemics, antihyperlipidemics, β-blockers, and opioids and exposures and poisonings among children 0 to 5, 6 to 12, and 13 to 19 years were analyzed by using multiple time-series analysis. Emergency department visits, serious injuries, and hospitalizations stemming from these associations were described.
Results: Adult medication prescriptions were statistically significantly associated with exposures and poisonings in children of all ages, with the strongest association observed for opioids. Across medications, the greatest risk was among children 0 to 5 years old, followed by 13- to 19-year-olds. Rates of emergency department visits were highest for events related to hypoglycemics (60.1%) and β-blockers (59.7%), whereas serious injuries and hospitalizations occurred most frequently with opioids (26.8% and 35.2%, respectively) and hypoglycemics (19.5% and 49.4%, respectively).
Conclusions: Increasing adult drug prescriptions are strongly associated with rising pediatric exposures and poisonings, particularly for opioids and among children 0 to 5 years old. These associations have sizable impacts, including high rates of serious injury and health care use.
Keywords: drug therapy; epidemiology; poisoning; prescription drugs; prevention and control.
Figures
FIGURE 1
Trends in pediatric exposures and poisonings related to oral hypoglycemics, antihyperlipidemics, β-blockers, and opioids and adult mentions of these medications. Exposures and poisonings increased statistically significantly for all age groups related to each of the drug classes (P < .001). Adult drug mentions increased statistically significantly for all drug classes (P < .001).
FIGURE 1
Trends in pediatric exposures and poisonings related to oral hypoglycemics, antihyperlipidemics, β-blockers, and opioids and adult mentions of these medications. Exposures and poisonings increased statistically significantly for all age groups related to each of the drug classes (P < .001). Adult drug mentions increased statistically significantly for all drug classes (P < .001).
FIGURE 2
Increases in pediatric exposures and poisonings associated with adult drug mentions of opioids, antihyperlipidemics, oral hypoglycemics, and β-blockers. Each bar indicates a month-specific mean predicted change in pediatric exposures and poisonings for a 1 percentage point increase in adult medication mentions. Lines show the corresponding confidence intervals estimated by using 1000 draws from the mean value’s variance-covariance matrix for the maximum likelihood estimate. Displayed numeric values represent the mean association averaging over 1 to 6 months.
FIGURE 2
Increases in pediatric exposures and poisonings associated with adult drug mentions of opioids, antihyperlipidemics, oral hypoglycemics, and β-blockers. Each bar indicates a month-specific mean predicted change in pediatric exposures and poisonings for a 1 percentage point increase in adult medication mentions. Lines show the corresponding confidence intervals estimated by using 1000 draws from the mean value’s variance-covariance matrix for the maximum likelihood estimate. Displayed numeric values represent the mean association averaging over 1 to 6 months.
Similar articles
- Emergency department visits by pediatric patients for poisoning by prescription opioids.
Tadros A, Layman SM, Davis SM, Bozeman R, Davidov DM. Tadros A, et al. Am J Drug Alcohol Abuse. 2016 Sep;42(5):550-555. doi: 10.1080/00952990.2016.1194851. Epub 2016 Jul 11. Am J Drug Alcohol Abuse. 2016. PMID: 27398815 Free PMC article. - National Trends in Hospitalizations for Opioid Poisonings Among Children and Adolescents, 1997 to 2012.
Gaither JR, Leventhal JM, Ryan SA, Camenga DR. Gaither JR, et al. JAMA Pediatr. 2016 Dec 1;170(12):1195-1201. doi: 10.1001/jamapediatrics.2016.2154. JAMA Pediatr. 2016. PMID: 27802492 Free PMC article. - Prevalence and Characteristics of Pediatric Opioid Exposures and Poisonings in the United States.
Patel AM, Wheeler DC, Rose SR, Nadpara PA, Pakyz AL, Carroll NV. Patel AM, et al. J Pediatr. 2019 Mar;206:148-155.e4. doi: 10.1016/j.jpeds.2018.10.047. Epub 2019 Jan 4. J Pediatr. 2019. PMID: 30612813 - Pediatric Pharmaceutical Ingestions.
Lowry JA, Burns M, Calello DP. Lowry JA, et al. Pediatr Ann. 2017 Dec 1;46(12):e459-e465. doi: 10.3928/19382359-20171122-01. Pediatr Ann. 2017. PMID: 29227522 Review. - Small dose... big poison.
Braitberg G, Oakley E. Braitberg G, et al. Aust Fam Physician. 2010 Nov;39(11):826-33. Aust Fam Physician. 2010. PMID: 21301654 Review.
Cited by
- Evaluation of Accidental and Intentional Pediatric Poisonings: Retrospective Analysis of Emergency Medical Service Interventions in Wroclaw, Poland.
Wojciechowki J, Czapla M, Konop M, Juárez-Vela R, Rosińczuk J. Wojciechowki J, et al. Nurs Rep. 2024 Sep 20;14(3):2523-2534. doi: 10.3390/nursrep14030186. Nurs Rep. 2024. PMID: 39311194 Free PMC article. - Trends in pediatric prescription-opioid overdoses in U.S. emergency departments from 2008-2020: An epidemiologic study of pediatric opioid overdose ED visits.
Lu A, Armstrong M, Alexander R, Vest E, Chang J, Zhu M, Xiang H. Lu A, et al. PLoS One. 2024 Apr 17;19(4):e0299163. doi: 10.1371/journal.pone.0299163. eCollection 2024. PLoS One. 2024. PMID: 38630653 Free PMC article. - General pattern of paediatric poisoning in Jordan during 2018-2019.
ALzayadneh EM, ALHadidi KA, Alasasfeh I, Battah A, Khasawneh SM, Faouri MN, Diab RW, Alzagareet YM, Abbas NH, Al-Debei RH, Zaqqa AM, Hadidi FK, Khraisat LM. ALzayadneh EM, et al. Toxicol Rep. 2024 Mar 21;12:369-374. doi: 10.1016/j.toxrep.2024.03.008. eCollection 2024 Jun. Toxicol Rep. 2024. PMID: 38572466 Free PMC article. - Opioids and Youth Athletes.
Benjamin HJ, Perri MM, Leemputte J, Lewallen L, DeVries C. Benjamin HJ, et al. Sports Health. 2024 Mar-Apr;16(2):269-278. doi: 10.1177/19417381241228629. Epub 2024 Feb 16. Sports Health. 2024. PMID: 38366642 Review. - Acute drug intoxication in childhood: a 10-year retrospective observational single-centre study and case reports.
Matalova P, Buchta M, Drietomska V, Spicakova A, Wawruch M, Ondra P, Urbanek K. Matalova P, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023 Sep;167(3):294-302. doi: 10.5507/bp.2023.032. Epub 2023 Jul 21. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023. PMID: 37580980
References
- Bronstein AC, Spyker DA, Cantilena LR, Jr, Green JL, Rumack BH, Giffin SL. 2009 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 27th Annual Report. Clin Toxicol (Phila). 2010;48(10):979–1178 - PubMed
- Lifshitz M, Gavrilov V. Acute poisoning in children. Isr Med Assoc J. 2000;2(7):504–506 - PubMed
- Olguin HJ, Garduño LB, Pérez JF, Pérez CF. Unintentional poisoning with drugs in a Mexican pediatric population. J Popul Ther Clin Pharmacol. 2011;18:e156–e160 - PubMed
- Shannon M. Ingestion of toxic substances by children. N Engl J Med. 2000;342(3):186–191 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources